Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications total healthcare cost offset associated switching oral antipsychotics aripiprazole once
… Society of Clinical Psychopharmacology. Risk of mortality associated with Pimavanserin compared with atypical antipsychotics in patients with Parkinson's disease–related …
… Uncovering Factors Associated with Adult Vaccination Coverage in the US Share …
… guidelines and patterns in clinical practice Clinical and cost effectiveness of comparator treatments Best practices in … disease area Economic model inputs including resource use, cost, and utility estimates Literature reviews often serve as …
… generation. The life sciences industry is facing a once-in-a-generation set of external stressors. Generational … widening gaps in access, quality, and affordability of healthcare. But what does all this mean for health systems … stressors? Health System Reforms Alongside the rising cost of living, the common denominator is the rising cost of …
… to Increase Vaccination in Older Adults Worth the Cost? Share on: October 5, 2021 Gaining optimal vaccination … But the number vaccinated is considered suboptimal. The cost of caring for persons with these diseases is substantial, but would the additional cost to increase vaccination rates provide an acceptable …
… Diseases (ESPID). Comparing the public health impact of switching to pediatric 13-valent pneumococcal conjugate …
… key factors which influence ICER’s rating decisions. A total of 68 evidence ratings were reviewed, across 17 … each rating. Assessments with ratings of B+ were typically associated with a substantial improvement in clinical …
… strategies 2) Analysis: Understand Your Product's Value Once current market conditions are understood, a market …
Longitudinal Modeling Approaches to Assess Association Between Two Clinical Outcomes Assessments Bintu Sherif, MS Director, Biostatistics Transcript With an increased regulatory focus on incorporating patient perspectives in drug development, …
… IPECAD Cross Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related … key role in pricing, access, and reimbursement decisions. Cost-effectiveness models for AD treatments face the common … on how treatment effects for new AD treatments are used in cost-effectiveness models. Such analyses are essential to the …